ULTRAGENYX PHARMACEUTICAL INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 38.91 USD | +2.34% |
|
-0.20% | -18.51% |
| 14/06 | Wedbush Adjusts Ultragenyx Pharmaceutical's Price Target to $45 From $48, Keeps Neutral Rating | MT |
| 14/06 | Sector Update: Health Care Stocks Lean Lower Pre-Bell Friday | MT |
MarketScreener Editorial Features
Search
 | Investors take a wait-and-see attitude ahead of central bank meetings | July 20, 2022 at 07:57 pm IST |
 | ANALYST RECOMMENDATIONS : Alphabet, Amazon, Chevron, Rio Tinto, Netflix... | July 20, 2022 at 03:11 pm IST |
 | Today on Wall Street: Is the economic recovery still on track? | August 04, 2021 at 06:54 pm IST |
 | ANALYST RECOMMENDATIONS : Chevron, Clorox, Nikola, Rambus, Rio Tinto.... | August 04, 2021 at 02:38 pm IST |
 | Today on Wall Street: The start of a new phase | June 30, 2021 at 06:17 pm IST |
 | ANALYST RECOMMENDATIONS : Apple, FedEx, Intellia Therapeutics, Reckitt Benckiser, XPO Logistics... | June 30, 2021 at 03:42 pm IST |
No results for this search
- Stock Market
- Equities
- RARE Stock
- News Ultragenyx Pharmaceutical Inc.
- MarketScreener Editorial Features
